Table 1.

Characteristics of the patients included in the ramosetron pharmacokinetic analysis

	0.3 mg (n = 17)	0.45 mg (n = 19)	0.6 mg (n = 22)
Age (years)	55.9 ± 9.3	61.5 ± 9.1	58.4 ± 13.9
Gender (male/female)	10/7	12/7	13/9
Weight (kg)	65.0 ± 9.1	64.7 ± 10.2	59.4 ± 8.2
Height (cm)	162.9 ± 7.7	162.4 ± 7.7	159.1 ± 7.8
Lean body mass * (kg)	47.0 (38.1–56.1)	51.6 (37.4–52.7)	46.0 (35.7–50.0)
Body mass index (kg∙m−2)	24.5 ± 2.5	24.5 ± 3.2	23.4 ± 2.2

Data are means ± SD, medians (25–75%), percentages or counts, as appropriate.

^* Calculated by the Janmahasatian formula. No statistical differences in parameters between groups (P > 0.05).